Founded in 1998 and headquartered in Chuncheon, South Korea, Boditech Med Inc. specializes in the development of in-vitro diagnostic solutions and reagents. The company's diverse product portfolio includes a range of advanced immunoassay analyzers designed to quantify analytes in various biological samples like blood, urine, and other body fluids. Key offerings include the ichroma II, an automated or semi-automated system for precise analyte measurement; AFIAS-6 and AFIAS-1, automated fluorescent immunoassay systems also designed for accurate quantification of targeted analytes; and the ichroma-50, an automatic immunoassay analyzer that determines analyte concentrations in bodily fluids. Additionally, the ichroma M2 is a portable analyzer suited for centralized hospital laboratories and physician's clinics, compatible with in-vitro diagnostic immunofluorescent assay kits for screening, monitoring, and routine examinations. Beyond these, Boditech Med also provides specialized diagnostic instruments such as the Ichroma TRIAS Reader, which measures targeted analyte concentration from diverse samples including blood, nasal, and nasopharyngeal swabs; the Hemochroma PLUS for quantitative total hemoglobin testing in blood; the i-chamber, an auxiliary component for ichroma systems; and the HandyRay, an innovative laser device facilitating needle-free capillary blood sampling. These diagnostic solutions address a broad spectrum of medical fields, including cardiac health, oncology, diabetes management, hormone analysis, infection, infectious diseases, gastrointestinal issues, and rheumatoid arthritis. Boditech Med Inc. distributes its products globally through a network of approximately 100 sales agencies.